Your basket is currently empty!
Mastering Immunity 2026 – Shanghai
Mastering Immunity 2026 – Shanghai, China
Immunogenicity Risk Management by Design for NMEs, Biologics and Complex Peptides
Monday 13 April – Tuesday 14 April 2026, In-person only
Shanghai International Convention Center, Oriental Riverside Hotel, Level 7 Pearl Room

Gain practical insights based on real world experience across modalities and approaches:
| Who will be attending?
|
Register Now – Complimentary Registrations Available
This in-person symposium in Shanghai brings together leaders in the biopharmaceutical industry around the world to discuss current and emerging best practice for managing immunogenicity risk in pharmaceutical development. We provide a particular focus around the rapidly evolving pharmaceutical development landscape in China and combine this with our speaker’s prior experience in the United States, Europe, and around the world in successfully managing immunogenicity risk over the last two decades.
Interested in presenting your work at this symposium? Click here to find out how you can get involved.
Confirmed Speakers (more coming soon)
Dr. Tim HicklingImplementing Immunogenicity Risk Assessment: Data integration, Simulations and Mitigations for Successful Product Launch Former Head of Immunosafety, Roche Quasor United Kingdom | Dr. Daniela VerthelyiTechnical and regulatory considerations regarding the assessment immunogenicity risk for new and follow on peptide and nucleic acid therapeutics Former Chief, Laboratory of Immunology, Office of Biotechnology Products, FDA United States of America | |
Dr. Balaji MRIntegrating In Silico and In Vitro Immunogenicity Risk Assessment: Strategies, Assay Selection, and Regulatory Challenges Vice President and Head-Non Clinical Dr. Reddy's Laboratories India | Dr. Peng LiData-Driven Immunogenicity Risk Assessment to Guide Antibody Therapeutic Development Associate Director, Global Safety Headquarters Eisai Japan | |
Andreas HollensteinUnmasking Hidden Epitopes: Bridging In Silico Prediction and MAPPs Detection in Immunogenicity Assessment Senior Principal Scientist, Immunosafety Roche Switzerland | Dr. Zuben SaunaDirector, Center for Biologics Evaluation and Research Food and Drug Administration United States of America | Dr. Kanthikiran VaranasiFrom Bench to Patient: A Strategic Approach for De-risking Biotherapeutic and Complex Generic Programs through Integrated Immunogenicity Assessment Global Head of Clinical Affairs and India Site Head Galenicum Health India |
Prof. Yoonjoo ChoiAllosteric deimmunisation of a Salmonella phosphatase enhances catalytic function Professor, Department of Microbiology and Immunology Chonnam National University Medical School South Korea |
Delegates by Organization include:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
What to Expect at this Meeting
|
|
Call for Abstracts & Poster Presentations
Key Details:
| Why Present?
|
| Review Process: All submissions will be evaluated by our Scientific Review Committee. Successful applicants will be notified of their acceptance for either oral presentation (selected top abstracts) or poster presentation as well as awarded with a free registration to this symposium. Grab your opportunity to contribute to this scientific dialogue, register now. |
|
Highlights from Previous Mastering Immunity Meetings are available online free of charge



ProImmune: Your Strategic Partner in Decoding Immunity
For 25 years, we’ve been pioneers in immunology research tools. We provide scientists with the innovative technologies – from MHC Multimer/Monomer products to our specialist in vitro and cell-based assay services to our groundbreaking Ankyron® platform.
By hosting global “Mastering Immunity” symposia, we connect the brightest minds to share cutting-edge knowledge and drive the field forward.
Venue
Shanghai International Convention Center, Oriental Riverside Hotel / 上海国际会议中心东方滨江大酒店
The venue is located in the heart of Lujiazui, boasting a prime riverside location on the banks of the Huangpu River. Adjacent to iconic attractions and commercial complexes including the Oriental Pearl TV Tower, Pudong Art Museum, Shanghai Ocean Aquarium, IFC Mall and Super Brand Mall, the hotel enjoys exceptional transportation accessibility.
You may book your stay at the Oriental Riverside Hotel, conveniently located at the symposium venue, at a special promotional rate by clicking here.

How to get there?
Venue Name / 场地名称: Shanghai International Convention Center, Oriental Riverside Hotel / 上海国际会议中心东方滨江大酒店
Address / 地址: 2727 Binjiang Avenue, Pudong New Area, Shanghai (near the Oriental Pearl TV Tower on Fenghe Road) / 海市浦东新区滨江大道2727号(丰和路近东方明珠电视塔)
By Public Transportation: Take Metro Line 2 to Lujiazui Station, Exit 2. Walk along the side of the entrance to the Oriental Pearl TV Tower for 7-8 minutes to reach the destination.
By Taxi: You may download the DiDi China ride-hailing app and enter the hotel address above as your destination. Alternatively, you can hail a taxi directly and show the driver the hotel address written in Chinese.
Registration Fee
First Two Registrations (Same Organization) | FREE* |
Standard Registration Fee for Additional Registrants | USD290 / EUR245 / GBP210 / CNY2,000^ |
| *Two complimentary admissions are available for applicants from the same organization, subject to submission of a brief justification in the application form below. | |
| ^Other countries are invoiced in GBP, with the exception of the USA and Canada, which are invoiced in USD, China invoiced in CNY. EUR are applicable for the following countries highlighted in the table here |
|
For all Conference Enquiries:
Email: enquiries@proimmune.com
WeChat: ProImmune


Dr. Tim Hickling
Dr. Daniela Verthelyi
Dr. Julia Rozenfeld
Dr. Balaji MR
Dr. Peng Li
Dr. Juhao Yang
Andreas Hollenstein
Dr. Zuben Sauna
Dr. Kanthikiran Varanasi
Prof. Yoonjoo Choi
Dr. Anuj Saini